Subscriptions: Want to stay updated? Click here to subscribe to our press releases
Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Feb  | Jan

	Dr Reddys Financial Results for the year 2000-2001. May 30, 2001
	Novartis granted exclusive rights for development and commercialisation of a novel insulin sensitiser from Dr Reddy's. May 29, 2001
	Dr Reddy's Laboratories to terminate GDS Program; Deposits of shares into ADS program facilitated May 8, 2001
	Dr. Venkateswarlu inducted into the Board of Directors of Dr Reddy's May 4, 2001

The information contained in the releases was current on the date they were issued and will become or may have become outdated over time. Dr. Reddy's does not assume any responsibility for updating
information in the releases.